You are managing a pharmaceutical research project with strict regulatory requirements. During quality inspections, you discover that 15% of the test samples from the last production batch do not meet the acceptance criteria defined in the quality management plan. The lab supervisor suggests reworking the samples, while the quality manager recommends disposing of the batch and starting over. The rework would save two weeks but carries some risk. What should you do?

Question

Accepted Answer

The correct answer is A. In a regulated environment, decisions must be based on the quality management plan, regulatory requirements, and established procedures rather than opinions or convenience. Reviewing these governing documents ensures compliance and appropriate action. Simply accepting one recommendation (option B) or prioritizing schedule over compliance (option C) ignores the need for documented, requirement-based decision-making. In pharmaceutical projects, regulatory compliance is non-negotiable, and decisions must be traceable and justified. A democratic vote (option D) is inappropriate for quality compliance decisions that must be based on requirements and standards, not popularity.

More Process Questions